Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
VaccinesInfectious Disease

PUBLISHER: Visiongain Reports Ltd. | PRODUCT CODE: 1211752

Cover Image

PUBLISHER: Visiongain Reports Ltd. | PRODUCT CODE: 1211752

Meningococcal Vaccines Market Report 2023-2033

PUBLISHED:
PAGES: 214 Pages
DELIVERY TIME: 1-2 business days
Get a Free Sample
Get More Info
SELECT AN OPTION
Unprintable PDF (Single User) - 1 Year License
USD 4938
PDF (Team License - Up to 6 Users) - 1 Year License
USD 5625
PDF (Site License)
USD 6875
PDF (Enterprise License - Includes Free Datasets)
USD 8688

Add to Cart

Description

Table of Contents

List of Tables

The global Meningococcal Vaccines market is projected to grow at a CAGR of 6.32% by 2033.

“The Meningococcal Vaccines Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Prevalence of Meningitis Driving Market Growth

Increasing adoption of meningococcal vaccines and the growing prevalence of meningitis and other viral diseases in developed as well as developing regions is anticipated to drive market growth. Also, the growing investment in R&D and novel drug launches for the treatment of viral diseases is further boosting the market growth. The developed regions including the U.S., Japan, and Europe accounted for a large share in the market is due to the well-developed healthcare infrastructure and better healthcare awareness in developed countries compared to developing countries. Thus, the demand for advanced and more efficient drugs is high in these regions. Whereas the market in emerging economies such as China, India, and South Africa is growing at a high pace owing to government initiatives, growing respiratory health awareness, and increasing disposable income.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the meningococcal vaccines market evolving?
  • What is driving and restraining the meningococcal vaccines market?
  • How will each meningococcal vaccines submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each meningococcal vaccines submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading meningococcal vaccines markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the meningococcal vaccines projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of meningococcal vaccines projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the meningococcal vaccines market?
  • Where is the meningococcal vaccines market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the meningococcal vaccines market today, and over the next 10 years:

  • Our 214-page report provides 83 tables and 132 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the meningococcal vaccines market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Vaccine Type

  • Conjugate
  • Polysaccharide
  • Others

Vaccine Brand

  • Bexsero
  • Menactra
  • Menveo
  • Others

End-users

  • Pediatric
  • Adult
  • Travelers

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 21 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Meningococcal Vaccines Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth:

  • BIO-MED
  • GSK plc
  • Incepta Pharmaceuticals Ltd.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi
  • Serum Institute of India Pvt. Ltd.
  • Walvax Biotechnology Co., Ltd.
  • Zhi Fei Biological

Overall world revenue for Meningococcal Vaccines Market, 2023 to 2033 in terms of value the market will surpass US$3,443.4 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Meningococcal Vaccines Market, 2023 to 2033 report help you?

In summary, our 210+ page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for Meningococcal Vaccines Market, 2023 to 2033 Market, with forecasts for Vaccine Type, Vaccine Brand, and End-users, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 21 key national markets - See forecasts for the Meningococcal Vaccines Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 9 of the major companies involved in the Meningococcal Vaccines Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Meningococcal Vaccines Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Show more
Product Code: PHA1228

Table of Contents

1. Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Meningococcal Vaccines Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Increasing Prevalence of Meningitis
      • 3.2.1.2 Increasing Initiatives by Government and Regulatory Authorities
      • 3.2.1.3 Presence of Non-profit Organizations Providing Funds for Research Projects
      • 3.2.1.4 Vaccine Trials Are Expected to be Commercialized During the Forecast Period
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Low Production Rate and High Cost
      • 3.2.2.2 High Costs of Drug Development Limits the Entry of New Players
      • 3.2.2.3 Long Vaccine Manufacturing Timelines to Impede the Growth of the Vaccines Market
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Increasing Inclusion in NIPs Unlocking New Windows of Opportunities
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Supplier: Moderate
    • 3.4.2 Bargaining Power of Buyer: Moderate
    • 3.4.3 Competitive Rivalry: High
    • 3.4.4 Threat of New Entrants: low
    • 3.4.5 Threat of Substitutes: Low
  • 3.5 PEST Analysis
    • 3.5.1 Political Factors Impacting Meningococcal Vaccines Market
    • 3.5.2 Economic Factors Impacting Meningococcal Vaccines Market
    • 3.5.3 Social Factors Impacting Meningococcal Vaccines Market
    • 3.5.4 Technological Factors Impacting Meningococcal Vaccines Market

4 Meningococcal Vaccines Market Analysis by Vaccine Type

  • 4.1 Key Findings
  • 4.2 Vaccine Type Segment: Market Attractiveness Index
  • 4.3 Meningococcal Vaccines Market Size Estimation and Forecast by Vaccine Type
  • 4.4 Conjugate
    • 4.4.1 Market Forecast by Region, 2023-2033 (US$ Mn)
    • 4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5 Polysaccharide
    • 4.5.1 Market Forecast by Region, 2023-2033 (US$ Mn)
    • 4.5.2 Market Share by Region, 2023 & 2033 (%)
  • 4.6 Others
    • 4.6.1 Market Forecast by Region, 2023-2033 (US$ Mn)
    • 4.6.2 Market Share by Region, 2023 & 2033 (%)

5 Meningococcal Vaccines Market Analysis by Vaccine Brand

  • 5.1 Key Findings
  • 5.2 Vaccine Brand Segment: Market Attractiveness Index
  • 5.3 Meningococcal Vaccines Market Size Estimation and Forecast by Vaccine Brand
  • 5.4 Bexsero
    • 5.4.1 Market Forecast by Region, 2023-2033 (US$ Mn)
    • 5.4.2 Market Share by Region, 2023 & 2033 (%)
  • 5.5 Menactra
    • 5.5.1 Market Forecast by Region, 2023-2033 (US$ Mn)
    • 5.5.2 Market Share by Region, 2023 & 2033 (%)
  • 5.6 Menveo
    • 5.6.1 Market Forecast by Region, 2023-2033 (US$ Mn)
    • 5.6.2 Market Share by Region, 2023 & 2033 (%)
  • 5.7 Others
    • 5.7.1 Market Forecast by Region, 2023-2033 (US$ Mn)
    • 5.7.2 Market Share by Region, 2023 & 2033 (%)

6 Meningococcal Vaccines Market Analysis by End-users

  • 6.1 Key Findings
  • 6.2 End-users Segment: Market Attractiveness Index
  • 6.3 Meningococcal Vaccines Market Size Estimation and Forecast by End-users
  • 6.4 Pediatric
    • 6.4.1 Market Forecast by Region, 2023-2033 (US$ Mn)
    • 6.4.2 Market Share by Region, 2023 & 2033 (%)
  • 6.5 Adult
    • 6.5.1 Market Forecast by Region, 2023-2033 (US$ Mn)
    • 6.5.2 Market Share by Region, 2023 & 2033 (%)
  • 6.6 Travelers
    • 6.6.1 Market Forecast by Region, 2023-2033 (US$ Mn)
    • 6.6.2 Market Share by Region, 2023 & 2033 (%)

7 Meningococcal Vaccines Market Analysis by Region

  • 7.1 Key Findings
  • 7.2 Regional Market Size Estimation and Forecast

8 North America Meningococcal Vaccines Market Analysis

  • 8.1 Key Findings
  • 8.2 North America Meningococcal Vaccines Market Attractiveness Index
  • 8.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
  • 8.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
  • 8.5 Market Size Estimation and Forecast by Vaccine Type, 2023-2033 (US$ Mn)
  • 8.6 Market Size Estimation and Forecast by Vaccine Brand, 2023-2033 (US$ Mn)
  • 8.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
  • 8.8 U.S. Meningococcal Vaccines Market Analysis
  • 8.9 Canada Meningococcal Vaccines Market Analysis

9 Europe Meningococcal Vaccines Market Analysis

  • 9.1 Key Findings
  • 9.2 Europe Meningococcal Vaccines Market Attractiveness Index
  • 9.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
  • 9.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
  • 9.5 Market Size Estimation and Forecast by Vaccine Type, 2023-2033 (US$ Mn)
  • 9.6 Market Size Estimation and Forecast by Vaccine Brand, 2023-2033 (US$ Mn)
  • 9.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
  • 9.8 Germany Meningococcal Vaccines Market Analysis
  • 9.9 UK Meningococcal Vaccines Market Analysis
  • 9.10 France Meningococcal Vaccines Market Analysis
  • 9.11 Italy Meningococcal Vaccines Market Analysis
  • 9.12 Spain Meningococcal Vaccines Market Analysis
  • 9.13 Russia Meningococcal Vaccines Market Analysis
  • 9.14 Rest of Europe Meningococcal Vaccines Market Analysis

10 Asia Pacific Meningococcal Vaccines Market Analysis

  • 10.1 Key Findings
  • 10.2 Asia Pacific Meningococcal Vaccines Market Attractiveness Index
  • 10.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
  • 10.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
  • 10.5 Market Size Estimation and Forecast by Vaccine Type, 2023-2033 (US$ Mn)
  • 10.6 Market Size Estimation and Forecast by Vaccine Brand, 2023-2033 (US$ Mn)
  • 10.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
  • 10.8 Japan Meningococcal Vaccines Market Analysis
  • 10.9 China Meningococcal Vaccines Market Analysis
  • 10.10 India Meningococcal Vaccines Market Analysis
  • 10.11 Australia Meningococcal Vaccines Market Analysis
  • 10.12 South Korea Meningococcal Vaccines Market Analysis
  • 10.13 Rest of Asia Pacific Meningococcal Vaccines Market Analysis

11 Latin America Meningococcal Vaccines Market Analysis

  • 11.1 Key Findings
  • 11.2 Latin America Meningococcal Vaccines Market Attractiveness Index
  • 11.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
  • 11.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
  • 11.5 Market Size Estimation and Forecast by Vaccine Type, 2023-2033 (US$ Mn)
  • 11.6 Market Size Estimation and Forecast by Vaccine Brand, 2023-2033 (US$ Mn)
  • 11.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
  • 11.8 Brazil Meningococcal Vaccines Market Analysis
  • 11.9 Mexico Meningococcal Vaccines Market Analysis
  • 11.10 Rest of Latin America Meningococcal Vaccines Market Analysis

12 MEA Meningococcal Vaccines Market Analysis

  • 12.1 Key Findings
  • 12.2 MEA Meningococcal Vaccines Market Attractiveness Index
  • 12.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
  • 12.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
  • 12.5 Market Size Estimation and Forecast by Vaccine Type, 2023-2033 (US$ Mn)
  • 12.6 Market Size Estimation and Forecast by Vaccine Brand, 2023-2033 (US$ Mn)
  • 12.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
  • 12.8 GCC Meningococcal Vaccines Market Analysis
  • 12.9 South Africa Meningococcal Vaccines Market Analysis
  • 12.10 Rest of MEA Meningococcal Vaccines Market Analysis

13 Company Profiles

  • 13.1 Pipeline Analysis
  • 13.2 Sanofi
    • 13.2.1 Company Snapshot
    • 13.2.2 Company Overview
    • 13.2.3 Financial Analysis
      • 13.2.3.1 Net Revenue, 2015-2021
      • 13.2.3.2 R&D Expenses, 2015-2021
      • 13.2.3.3 Gross Profit, 2015-2021
      • 13.2.3.4 Regional Market Share, 2021
    • 13.2.4 Product Benchmarking
    • 13.2.5 Strategic Outlook
  • 13.3 Merck & Co., Inc.
    • 13.3.1 Company Snapshot
    • 13.3.2 Company Overview
    • 13.3.3 Financial Analysis
      • 13.3.3.1 Net Revenue, 2015-2021
      • 13.3.3.2 R&D Expenses, 2015-2021
      • 13.3.3.3 Gross Profit, 2015-2021
      • 13.3.3.4 Regional Market Share, 2021
    • 13.3.4 Product Benchmarking
  • 13.4 GSK plc
    • 13.4.1 Company Snapshot
    • 13.4.2 Company Overview
    • 13.4.3 Financial Analysis
      • 13.4.3.1 Net Revenue, 2015-2021
      • 13.4.3.2 R&D Expenses, 2015-2021
      • 13.4.3.3 Gross Profit, 2015-2021
      • 13.4.3.4 Regional Market Share, 2021
    • 13.4.4 Product Benchmarking
    • 13.4.5 Strategic Outlook
  • 13.5 Pfizer Inc.
    • 13.5.1 Company Snapshot
    • 13.5.2 Company Overview
    • 13.5.3 Financial Analysis
      • 13.5.3.1 Net Revenue, 2015-2021
      • 13.5.3.2 R&D Expenses, 2015-2021
      • 13.5.3.3 Gross Profit, 2015-2021
      • 13.5.3.4 Regional Market Share, 2021
    • 13.5.4 Product Benchmarking
    • 13.5.5 Strategic Outlook
  • 13.6 Serum Institute of India Pvt. Ltd.
    • 13.6.1 Company Snapshot
    • 13.6.2 Company Overview
    • 13.6.3 Product Benchmarking
  • 13.7 Zhi Fei Biological
    • 13.7.1 Company Snapshot
    • 13.7.2 Company Overview
    • 13.7.3 Product Benchmarking
  • 13.8 Incepta Pharmaceuticals Ltd.
    • 13.8.1 Company Snapshot
    • 13.8.2 Company Overview
    • 13.8.3 Product Benchmarking
  • 13.9 Walvax Biotechnology Co., Ltd.
    • 13.9.1 Company Snapshot
    • 13.9.2 Company Overview
    • 13.9.3 Product Benchmarking
  • 13.10 BIO-MED
    • 13.10.1 Company Snapshot
    • 13.10.2 Company Overview
    • 13.10.3 Product Benchmarking

14 Conclusion and Recommendations

  • 14.1 Concluding Remarks from
  • 14.2 Recommendations for Market Players
Show more
Product Code: PHA1228

List of Tables

  • Table 1 Meningococcal Vaccines Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
  • Table 2 Meningococcal Vaccines Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 3 Meningococcal Vaccines Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 4 Meningococcal Vaccines Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 5 Meningococcal Vaccines Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 6 Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 7 Conjugate Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 8 Polysaccharide Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 9 Others Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 10 Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 11 Bexsero Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 12 Menactra Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 13 Menveo Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 14 Others Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 15 Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 16 Pediatric Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 17 Adult Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 18 Travelers Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
  • Table 19 Meningococcal Vaccines Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 20 North America Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 21 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 22 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 23 North America Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 24 U.S. Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 25 Canada Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 26 Europe Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 27 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 28 Europe Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 29 Europe Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 30 Germany Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 31 UK Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 32 France Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 33 Italy Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 34 Spain Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 35 Russia Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 36 Rest of Europe Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 37 Overview of the Epidemiology and Prevention of IMD Across the Asia-Pacific Region
  • Table 38 Asia Pacific Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 39 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 40 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 41 Asia Pacific Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 42 Japan Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 43 China Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 44 India Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 45 Australia Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 46 South Korea Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 47 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 48 Latin America Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 49 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 50 Latin America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 51 Latin America Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 52 Brazil Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 53 Mexico Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 54 Rest of Latin America Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 55 MEA Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 56 MEA Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 57 MEA Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 58 MEA Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 59 GCC Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 60 South Africa Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 61 Rest of MEA Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
  • Table 62 Meningococcal Vaccine: Pipeline Analysis
  • Table 63 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 64 Sanofi: Product Benchmarking
  • Table 65 Sanofi: Strategic Outlook
  • Table 66 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 67 Merck & Co., Inc.: Product Benchmarking
  • Table 68 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 69 GSK plc: Product Benchmarking
  • Table 70 GSK plc: Strategic Outlook
  • Table 71 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 72 Pfizer Inc.: Product Benchmarking
  • Table 73 Pfizer Inc.: Strategic Outlook
  • Table 74 Serum Institute of India Pvt. Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 75 Serum Institute of India Pvt. Ltd.: Product Benchmarking
  • Table 76 Zhi Fei Biological: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 77 Zhi Fei Biological: Product Benchmarking
  • Table 78 Incepta Pharmaceuticals Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 79 Incepta Pharmaceuticals Ltd.: Product Benchmarking
  • Table 80 Walvwax Biotechnology Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 81 Walvax Biotechnology Co., Ltd.: Product Benchmarking
  • Table 82 BIO-MED: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 83 BIO-MED: Product Benchmarking
  •  

List of Figures

  • Figure 1 Meningococcal Vaccines Market Segmentation
  • Figure 2 Meningococcal Vaccines Market by Vaccine Type: Market Attractiveness Index
  • Figure 3 Meningococcal Vaccines Market by End-users: Market Attractiveness Index
  • Figure 4 Meningococcal Vaccines Market Attractiveness Index by Region
  • Figure 5 Meningococcal Vaccines Market: Market Dynamics
  • Figure 6 Meningococcal Vaccines Market by Region, 2023-2033 (US$ Mn, AGR %): "V" Shaped Recovery
  • Figure 7 Meningococcal Vaccines Market by Region, 2023-2033 (US$ Mn, AGR %): "U" Shaped Recovery
  • Figure 8 Meningococcal Vaccines Market by Region, 2023-2033 (US$ Mn, AGR %): "W" Shaped Recovery
  • Figure 9 Meningococcal Vaccines Market by Region, 2023-2033 (US$ Mn, AGR %): "L" Shaped Recovery
  • Figure 10 Meningococcal Vaccines Market: Porter's Five Forces Analysis
  • Figure 11 Meningococcal Vaccines Market: PEST Analysis
  • Figure 12 Meningococcal Vaccines Market Attractiveness Index by Vaccine Type
  • Figure 13 Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ million)
  • Figure 14 Meningococcal Vaccines Market Share Forecast by Vaccine Type, 2023, 2028, 2033 (%)
  • Figure 15 Conjugate Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 16 Conjugate Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 17 Polysaccharide Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 18 Polysaccharide Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 19 Others Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 20 Others Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 21 Meningococcal Vaccines Market Attractiveness Index by Vaccine Type
  • Figure 22 Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ million)
  • Figure 23 Meningococcal Vaccines Market Share Forecast by Vaccine Brand, 2023, 2028, 2033 (%)
  • Figure 24 Bexsero Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 25 Bexsero Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 26 Menactra Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 27 Menactra Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 28 Menveo Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 29 Menveo Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 30 Others Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 31 Others Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 32 Meningococcal Vaccines Market Attractiveness Index by End-users
  • Figure 33 Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ million)
  • Figure 34 Meningococcal Vaccines Market Share Forecast by End-users, 2023, 2028, 2033 (%)
  • Figure 35 Pediatric Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 36 Pediatric Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 37 Adult Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 38 Adult Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 39 Travelers Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 40 Travelers Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 41 Meningococcal Vaccines Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
  • Figure 42 Meningococcal Vaccines Market Share Forecast by Region 2023, 2028, 2033 (%)
  • Figure 43 Meningococcal Vaccines Market by Region, 2023-2033 (US$ Mn)
  • Figure 44 North America Meningococcal Vaccines Market Attractiveness Index
  • Figure 45 North America Meningococcal Vaccines Market by Region, 2023, 2028 & 2033 (US$ million)
  • Figure 46 North America Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ million)
  • Figure 47 North America Meningococcal Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 48 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ million)
  • Figure 49 North America Meningococcal Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
  • Figure 50 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ million)
  • Figure 51 North America Meningococcal Vaccines Market Share Forecast by Vaccine Brand, 2023 & 2033 (%)
  • Figure 52 North America Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ million)
  • Figure 53 North America Meningococcal Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
  • Figure 54 U.S. Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 55 Canada Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 56 Europe Meningococcal Vaccines Market Attractiveness Index
  • Figure 57 Europe Meningococcal Vaccines Market by Region, 2023, 2028 & 2033 (US$ million)
  • Figure 58 Europe Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ million)
  • Figure 59 Europe Meningococcal Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 60 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ million)
  • Figure 61 Europe Meningococcal Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
  • Figure 62 Europe Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ million)
  • Figure 63 Europe Meningococcal Vaccines Market Share Forecast by Vaccine Brand, 2023 & 2033 (%)
  • Figure 64 Europe Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ million)
  • Figure 65 Europe Meningococcal Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
  • Figure 66 Germany Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 67 UK Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 68 France Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 69 Italy Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 70 Spain Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 71 Russia Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 72 Rest of Europe Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 73 Asia Pacific Meningococcal Vaccines Market Attractiveness Index
  • Figure 74 Asia Pacific Meningococcal Vaccines Market by Region, 2023, 2028 & 2033 (US$ million)
  • Figure 75 Asia Pacific Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ million)
  • Figure 76 Asia Pacific Meningococcal Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 77 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ million)
  • Figure 78 Asia Pacific Meningococcal Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
  • Figure 79 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ million)
  • Figure 80 Asia Pacific Meningococcal Vaccines Market Share Forecast by Vaccine Brand, 2023 & 2033 (%)
  • Figure 81 Asia Pacific Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ million)
  • Figure 82 Asia Pacific Meningococcal Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
  • Figure 83 Japan Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 84 China Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 85 India Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 86 Number of IMD Cases in Australia, 1991-2021
  • Figure 87 Proportion of Serogroups of Laboratory-Confirmed IMD, Australia, 2000 - 2021
  • Figure 88 Australia Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 89 South Korea Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 90 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 91 Latin America Meningococcal Vaccines Market Attractiveness Index
  • Figure 92 Latin America Meningococcal Vaccines Market by Region, 2023, 2028 & 2033 (US$ million)
  • Figure 93 Latin America Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ million)
  • Figure 94 Latin America Meningococcal Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 95 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ million)
  • Figure 96 Latin America Meningococcal Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
  • Figure 97 Latin America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ million)
  • Figure 98 Latin America Meningococcal Vaccines Market Share Forecast by Vaccine Brand, 2023 & 2033 (%)
  • Figure 99 Latin America Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ million)
  • Figure 100 Latin America Meningococcal Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
  • Figure 101 Brazil Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 102 Mexico Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 103 Rest of Latin America Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 104 MEA Meningococcal Vaccines Market Attractiveness Index
  • Figure 105 MEA Meningococcal Vaccines Market by Region, 2023, 2028 & 2033 (US$ million)
  • Figure 106 MEA Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ million)
  • Figure 107 MEA Meningococcal Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 108 MEA Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ million)
  • Figure 109 MEA Meningococcal Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
  • Figure 110 MEA Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ million)
  • Figure 111 MEA Meningococcal Vaccines Market Share Forecast by Vaccine Brand, 2023 & 2033 (%)
  • Figure 112 MEA Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ million)
  • Figure 113 MEA Meningococcal Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
  • Figure 114 GCC Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 115 South Africa Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 116 Rest of MEA Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 117 Sanofi: Net Revenue, 2015-2021 (US$ million, AGR%)
  • Figure 118 Sanofi: R&D Expenses, 2015-2021 (US$ million, AGR%)
  • Figure 119 Sanofi: Gross Profit, 2015-2021 (US$ million, AGR%)
  • Figure 120 Sanofi: Regional Market Share, 2021
  • Figure 121 Merck & Co. Inc.: Net Revenue, 2015-2021 (US$ million, AGR%)
  • Figure 122 Merck & Co. Inc.: R&D Expenses, 2015-2021 (US$ million, AGR%)
  • Figure 123 Merck & Co. Inc.: Gross Profit, 2015-2021 (US$ million, AGR%)
  • Figure 124 Merck & Co. Inc.: Regional Market Share, 2021
  • Figure 125 GSK plc: Net Revenue, 2015-2021 (US$ million, AGR%)
  • Figure 126 GSK plc: R&D Expenses, 2015-2021 (US$ million, AGR%)
  • Figure 127 GSK plc.: Gross Profit, 2015-2021 (US$ million, AGR%)
  • Figure 128 GSK plc: Regional Market Share, 2021
  • Figure 129 Pfizer Inc.: Net Revenue, 2015-2021 (US$ million, AGR%)
  • Figure 130 Pfizer Inc.: R&D Expenses, 2015-2021 (US$ million, AGR%)
  • Figure 131 Pfizer Inc.: Gross Profit, 2015-2021 (US$ million, AGR%)
  • Figure 132 Pfizer Inc.: Regional Market Share, 2021
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!